FDA issues new warning on misuse of UCB cough drug

03/12/2008 | Yahoo!

The FDA on Tuesday released a new warning on the potentially lethal side effects of misusing Tussionex Pennkinetic Extended-Release Suspension, a cough treatment manufactured by UCB S.A. The agency received reports of health problems and deaths in children and adults who took the drug, which contains hydrocodone, a narcotic pain reliever. "The FDA's alert is fully in line with our efforts to make sure this product is properly used," a UCB spokewoman said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX